APRIL 2018 NEWSFEED

  • Diet Soda, Sweeteners Can Still Cause Diabetes, Study Finds
    Although many people think diet soda is a healthier option than other sugary drinks, a new study has found that having beverages using artificial sweeteners can still lead to diabetes and obesity. Researchers from the Medical College of Wisconsin say a study of rats has revealed that artificial sweeteners, commonly used in zero-calorie sodas, actually did as much harm to the body as a high-sugar diet. Read the full press release here: CBS SF Local
  • New Hope for Treating Diabetic Wounds that just Won’t Heal
    One of the most frustrating and debilitating complications of diabetes is the development of wounds on the foot or lower leg. Once they form, they can persist for months, leading to painful and dangerous infections. New research uncovers the role of a particular protein in maintaining these wounds and suggests that reversing its effects could help aid wound healing in patients with diabetes.”We discovered that a specific protein, thrombospondin-2 (TSP2), is elevated in wounds of patients with diabetes as well as in animal models of diabetes,” said Britta Kunkemoeller, a doctoral student at Yale University who conducted the study. Read the full story here: EurekAlert
  • Detecting Diabetic Never Damage in Ten Minutes by Magnifying the Cornea
    Swedish researchers have highlighted that examining corneal nerve fibre density could be a way of detecting the extent of diabetic nerve damage. Scientists at Umea University in Sweden examined the eyes of 82 people with and without Type 2 diabetes using confocal microscopy and wide-area mosaic analysis. Corneal nerve density was thinner in people with Type 2 diabetes compared to healthy study participants. Read the full story here: Optometry Today.
  • FDA Approves Marketing of Device That Can Help Detect Irreversible Diabetic Retinopathy
    The device, called the IDx-DR, may help increase access to diagnostic tools for diabetes-related vision loss, but only if physicians decide to adopt it in their practice. A medical device that uses artificial intelligence (AI) to detect vision loss in people with type 2 diabetes is now available to the general public after the Food and Drug Administration (FDA) fast-tracked its approval earlier this year. Read the full story here: EveryDay Health
Disclaimer. The content, information, and links on this page are intended for informational and educational purposes only, and does NOT constitute any medical professional advice.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.